 |
|
Theodore J. Chiacchio, Esq. – Registered Patent Attorney |
|
Patent law expert that you can trust will provide highly competent service in a cost-effective manner. |
|
I partner with my clients to provide easy-to-understand, practical answers and strategy in a cost-effective manner. If there is a matter that could benefit from patent law expertise tailored to the pharmaceutical arts, I would be happy to discuss the matter with you. |
|
 |
|
|
• |
Over 15 years practicing patent law (approximately 95% of that experience has come while serving clients in the pharmaceutical industry). |
• |
Extensive experience on both the brand/NDA side and the generic/ANDA side. |
• |
Have prepared dozens of Opinions of Counsel and have spent over a decade representing pharmaceutical companies in connection with Hatch-Waxman and other patent infringement litigation. |
• |
Representative clients include GlaxoSmithKline, Daiichi-Sankyo, Mylan Pharmaceuticals, Lupin Pharmaceuticals, Apotex Inc., Baxalta, Catalent, Alembic Pharmaceuticals, Aurobindo Pharma, and Perrigo Company. |
• |
Representative matters have concerned the following drugs (among others): darunavir (Prezista®), capecitabine (Xeloda®), ranolazine (Ranexa®), guaifenesin (Mucinex®), mometasone furoate (Nasonex®), bimatoprost (Lumigan® .01%), ondansetron (Zofran®), ofloxacin (Floxin Otic®), levetiracetam (Keppra®), carbamazepine (Carbatrol®), nisoldipine (Sular®), pantoprazole (Protonix®), doxercalciferol (Hectorol®), paricalcitol (Zemplar®), fenofibrate (Tricor®), escitalopram (Lexapro®), desloratadine (Clarinex®), ibandronate (Boniva®), rosuvastatin calcium (Crestor®), PEGylated rFVIII (Adynovate®), atorvastatin calcium (Lipitor®), lamivudine/zidovudine (Combivir®), memantine (Namenda®), bupropion HCl (Welbutrin®), budesonide inhalation suspension (Pulmicort Respules®), and cefuroxime axetil (Ceftin®). |
|
|
|
Theodore J. Chiacchio
Partner, SpencePC
405 N. Wabash Avenue, Suite P2E
Chicago, Illinois 60611
Email: ted.chiacchio@spencepc.com
Phone: (312) 635-5511
|
|
 |
|
|
|
|
|
|